SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals is drawing heavy attention after Trump announced a US-Denmark-Greenland agreement granting the US permanent security access to Greenland and barring adversary investments, which traders view as a strategic tailwind for the company's Tanbreez rare earth project there. Sentiment is overwhelmingly bullish, with heavy short-squeeze speculation given elevated short interest, though skeptics argue the pactnot yet formally signeddoesn't change Tanbreez's funding or production timeline.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Conversation centers on Meta's Muse AI agent, with traders celebrating its climb to the top of app store charts and sharing early experiences using it for tasks like travel booking and email management, viewing the launch as evidence Meta can monetize AI ahead of the Meta Connect conference. Skeptics counter that Muse generates no revenue yet, citing sluggish performance and reports that Amazon blocked the agent's agentic shopping, leaving sentiment divided despite the buzz.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUI is seeing renewed attention as a sharp rally pushes the token back toward the closely watched one-dollar level, reigniting a bull-versus-bear debate. Bulls cite ETF accumulation, staking, and supply-squeeze tokenomics as fuel for further upside, while bears dismiss the move and point to past network outages and the protocol's asset-freezing capabilities as unresolved red flags.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is bouncing sharply alongside the semiconductor-equipment group as chip stocks lead a broader market rebound, with traders citing heavy options activity and headlines such as SK Hynix's Solidigm exploring a first US NAND fab and Lam's equipment push into India as possible triggers. The community is divided on whether the move marks a durable bottom or a dead-cat bounce after a steep correction blamed on AI-capex slowdown fears, with recurring market-maker manipulation claims also running through the discussion.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is drawing attention as the token rallies off long-standing lows toward key resistance on elevated volume, a move many traders link to the leadership change that installed William Herkelrath as CEO in place of Staci Warden. Bulls view the new leadership alongside post-quantum mainnet upgrades as a potential turning point, while bears counter that foundation token sales and dilution will keep capping any recovery.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

Wells Fargo initiated coverage of TeraWulf with an Overweight rating and a bullish price target, becoming the dominant topic as traders also flag reported open-market insider purchases by a board member. The community is split between bulls viewing the rating as validation of the company's AI/HPC data-center pivot and its heavy short interest as squeeze fuel, and skeptics citing the stock's steep slide from its mid-year highs, insider selling, and financing and execution risk.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending after its investor day produced a cluster of announcements  a raised full-year 2026 revenue outlook incorporating the SkyWater acquisition, the unveiling of its sixth-generation Superion 256 quantum platform, and a commercial quantum-security agreement with Congruity360  which initially sparked a sharp rally before the stock gave back most of the gains. Community reaction is split, with bulls citing the guidance raise, manufacturing scale, and analyst support, while bears point to the sell-the-news fade, CEO share sales, and pressure from rising rates.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is surging sharply after the launch of confidential perpetual futures powered by Hyperliquid, a privacy-first trading feature that traders are crediting for the explosive move. Community sentiment is largely bullish, with many framing the rally as part of a broader altcoin rotation and the privacy/AI narrative alongside Zcash, while skeptics argue the pump is whale-driven and lacks fundamental news.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is trending on a cluster of open-market insider purchases, with CEO John Fieldly and multiple directors buying shares in quick succession. Bulls frame the repeated insider buys as a strong conviction signal and a potential bottom, while skeptics call the purchases too small to offset concerns over core-brand volume pressure and ongoing criticism of management.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti is drawing heavy attention after signing a definitive agreement with the U.S. Department of Commerce for up to $100 million in CHIPS Act funding to accelerate superconducting quantum R&D, with the government receiving a minority equity stake as part of a broader wave of government investments in quantum firms. Traders are split between viewing the government backing as validation of the pure-play quantum company's strategic importance and warning that the newly issued shares to the government dilute existing holders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NVS Stock Clocks Worst Day In Over 20 Years After Second Trial Failure In A Week — DYN, SRPT Slip In Sympathy

Equity

The company said on Tuesday that its experimental drug del-desiran failed in a late-stage trial. 

A Rivals Clinical Stumble Sends Sarepta Therapeutics Stock Lower

Sarepta Therapeutics shares react to Novartis Phase 3 trial results in DM1 while Sarepta progresses its SRP-1003 RNA therapy clinical trials.read more...

Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2026-2027 Academic Year

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced 25 recipients of Route 79, The Duchenne Scholarship Program, for the 2026-2027 academic year. Of the academic scholarships, 20 will be awarded to individuals living with Duchenne...

Sarepta Therapeutics Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sarepta Therapeutics, Inc. - SRPT

Sarepta Therapeutics Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sarepta Therapeutics, Inc. - SRPT Sarepta Therapeutics Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sarepta Therapeutics, Inc. - SRPT PR...

Why Is Sarepta Therapeutics (SRPT) Up 37% Since Last Earnings Report?

Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sarepta Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, Sept. 14, at 8:30 a.m. ET. The presentation will...

SRPT On Track For Best Week In 5 Months Ahead Of Late-2026 Clinical Data — Retail Eyes ‘Monumental Comeback’

Investors are now awaiting extra data from Sarepta’s mid-stage studies in two muscle diseases, facioscapulohumeral muscular dystrophy and myotonic dystrophy.


KROS $20M Takeda Milestone Adds Cash but Revenue Visibility Stays Weak

Keros gets a $20M Takeda milestone, boosting cash and flexibility, but weak revenue visibility keeps collaboration income in focus.

Should You Buy KROS Stock as Pipeline Promise Meets Revenue Risk?

Keros' rinvatercept pipeline offers upside, but zero quarterly revenue, clinical risk and a premium valuation make the stock a cautious bet.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Sarepta Therapeutics, Inc. (NasdaqGS: SRPT) (Sarepta or the Company).Sarepta is a biopharmaceutical company focused on...

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$20.11
Prev Close	$20.67
Open	$20.63
Dividend Yield	0.00%
50-Day Moving Average	$18.55
Beta	1.27
Avg. Volume	2.99M
PE Ratio	-6.94

52-Week High	$25.32
52-Week Low	$14.68
Market Capitalization	$2.12B
EPS (Annual)	-$7.13
Price to Book	1.39
Revenue Per Employee	$2.63M

Feed

News

Sentiment

Earnings

Fundamentals

Info

SRPT Fundamentals